Online citations, reference lists, and bibliographies.

Combined Vitamin B6-magnesium Treatment In Autism Spectrum Disorder.

Chad Nye, Anne Brice
Published 2002 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND The use of mega-vitamin intervention began in the early 1950's with the treatment of schizophrenic patients. Pyroxidine (vitamin B6) was first used with children diagnosed with "autism syndrome" when speech and language improvement was observed in some children as a result of large doses of B6. A number of published studies attempted to assess the effects of vitamin B6-Mg (Mg was found to reduce undesirable side effects from B6) on a variety of characteristics such as verbal communication, non-verbal communication, interpersonal skills, and physiological function, in individuals with autism. OBJECTIVES To determine the efficacy of vitamin B6 and magnesium (B6-Mg) for treating social, communication and behavioural responses of children and adults with autism. SEARCH STRATEGY We searched the Cochrane Controlled Trials Register (Cochrane Library, Issue 2, 2002), MEDLINE (1966- January 2002), EMBASE (1980-January 2002), PsychINFO (1887 - January 2002), Dissertation Abstracts International (1861 - January 2002). The search engine FirstSearch was also used (January 2002). Reference lists for all the obtained studies and other review articles were examined for additional studies. SELECTION CRITERIA All studies in which the participants were randomly allocated prior to intervention and in which outcomes were compared to either a placebo or non-treated group were included. DATA COLLECTION AND ANALYSIS Two reviewers independently evaluated all potential studies identified as indicated above for inclusion. MAIN RESULTS Two trials were included in the review. Both studies used a double-blind crossover design. One study (Tolbert 1993) provided insufficient data to conduct an analysis. The senior author was contacted for supporting data but was unable to provide the needed information. The remaining study (Findling, 1997) yielded no significant differences between treatment and placebo group performances following the B6 intervention on measures of social interaction, communication, compulsivity, impulsivity, or hyperactivity. REVIEWER'S CONCLUSIONS Due to the small number of studies, the methodological quality of studies, and small sample sizes, no recommendation can be advanced regarding the use of B6-Mg as a treatment for autism.



This paper is referenced by
10.1038/s41598-018-33110-w
Potential identification of vitamin B6 responsiveness in autism spectrum disorder utilizing phenotype variables and machine learning methods
Taku Obara (2018)
[Good practice guidelines for the treatment of autistic spectrum disorders].
Joaquín Fuentes-Biggi (2006)
10.1155/2012/870391
A Review of Complementary and Alternative Treatments for Autism Spectrum Disorders
Nicholas Lofthouse (2012)
10.1542/peds.2019-3447
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Susan L. Hyman (2020)
10.3390/ijerph17082647
The Role of Microbiome, Dietary Supplements, and Probiotics in Autism Spectrum Disorder
Bhagavathi Sundaram Sivamaruthi (2020)
10.5772/18512
Intervention Models in Children with Autism Spectrum Disorders
Gonzalo Ros Cervera (2011)
10.1186/s13229-016-0109-5
Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism
Federica Gevi (2016)
10.1037/e533422010-001
Interventions for Autism Spectrum Disorders: State of the Evidence
Mph Lindsey Tweed Md (2009)
10.1016/S1474-4422(20)30034-X
Evidence-based support for autistic people across the lifespan: maximising potential, minimising barriers, and optimising the person–environment fit
Meng-Chuan Lai (2020)
10.3390/molecules25030564
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
Masaru Tanaka (2020)
10.1177/1362361306057876
Screening for autism spectrum disorders
Jo Williams (2006)
10.1155/2015/258589
Complementary and Alternative Therapies for Autism Spectrum Disorder
Natascia Brondino (2015)
10.1093/nutrit/nuz092
Nutritional interventions for autism spectrum disorder.
Elisa Karhu (2019)
10.1002/9781118660584.ESE1263
Interventions for Autism Spectrum Disorders
Jennifer B. Ganz (2014)
10.1177/1362361307078132
Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder
Marita Broadstock (2007)
10.1542/PEDS.2007-2362
Management of Children With Autism Spectrum Disorders
Scott M. Myers (2007)
10.15123/PUB.3452
Mothers' experiences of a primary specialist provision for autism attended by their child
Emma K. Read (2013)
10.4103/0256-4947.65261
Autism spectrum disorders
Hadeel Faras (2010)
10.2147/RMHP.S4652
The practice and regulatory requirements of naturopathy and western herbal medicine in Australia
Vivian Wenli Lin (2009)
Educating pharmacists and the public about the role of over-the-counter medications in the management of Autism Spectrum Disorders
Jillian M. Bankoff (2014)
10.9758/cpn.2018.16.4.383
The Levels of Vitamin D, Vitamin D Receptor, Homocysteine and Complex B Vitamin in Children with Autism Spectrum Disorders
Hatice Uludağ Altun (2018)
10.1542/PEDS.2006-3503
Effectiveness of Highly Active Antiretroviral Therapy in HIV-Positive Children: Evaluation at 12 Months in a Routine Program in Cambodia
Bart Janssens (2007)
10.1517/14656566.8.11.1579
The status of pharmacotherapy for autism spectrum disorders
Scott M. Myers (2007)
10.1017/S0954422414000110
Autism and nutrition: the role of the gut-brain axis.
Marijke M H van De Sande (2014)
10.1016/j.wneu.2016.09.100
Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking?
Senthilkumar Sivanesan (2017)
10.1002/mrdd.20062
Novel treatments for autistic spectrum disorders.
Susan E Levy (2005)
10.1590/1516-3180.2017.0058200317
What do Cochrane systematic reviews say about interventions for autism spectrum disorders?
Larissa Lyra (2017)
10.3310/hta19410
Systematic review of tools to measure outcomes for young children with autism spectrum disorder.
Helen McConachie (2015)
10.1097/YPG.0b013e32832cebd2
Aberrations in folate metabolic pathway and altered susceptibility to autism
Naushad Shaik Mohammad (2009)
Semantic Scholar Logo Some data provided by SemanticScholar